Portal de investigación
The 3-Day Bladder Diary Is a Feasible, Reliable and Valid Tool to Evaluate the Lower Urinary Tract Symptoms in Women
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jimenez-Cidre, MA
- Lopez-Fando, L
- Esteban-Fuertes, M
- Prieto-Chaparro, L
- Llorens-Martinez, FJ
- Salinas-Casado, J
- Castro-Diaz, D
- Muller-Arteaga, C
- Adot-Zurbano, JM
- Rodriguez-Escobar, F
- Gutierrez, C
- Madurga-Patuel, B
- Leva-Vallejo, M
- Franco de Castro, A
- Peri-Cusi, L
- Conejero-Sugranes, J
- Jimenez-Calvo, J
- Rebollo, P
- Mora, A
Grupos
Abstract
AimsTo evaluate the feasibility (% of completion), reliability (test-retest and inter-observer) and validity (convergent vs. questionnaires and vs. urodynamic study-UDS) of the 3-day bladder diary (3dBD) in women with lower urinary tract symptoms (LUTS). MethodsEpidemiological, descriptive, cross-sectional and prospective study. Fourteen Functional Urology and Urodynamic Units participated. One hundred thirty-six women with mean age (SD) 55.2 (13.8) years with LUTS, without bladder catheterization and who were able to fill in the 3dBD were included. An UDS was performed. They filled in the 3dBD in two times separated by 15 days (test and retest), the International Consultation on IncontinenceShort Form (ICIQ-UI SF) and the Bladder Control Self-Assessment Questionnaire (BSAQ). ResultsOne hundred ten women completed 3dBD for test and retest. Feasibility: each 3dBD has 42 variables, 77.2% women completed 80%. Test-retest reliability: there were not differences in the proportion of patients classified as positive for each symptom (urgency: P=0.3173; incontinence: P=1; nocturia: P=0.0522; frequency: P=0.4386). The Intraclass Correlation Coefficient (ICC) ranged from 0.67 to 0.92, except for night time VVmax which was lower (0.54). Inter-observer reliability: ICC ranged from 0.64 to 0.99, except for day time VVmax (0.29) and the number of urgency episodes (0.45). Validity: Spearman correlation coefficients for ICIQ-UI SF and BSAQ ranged from 0.4 to 0.6 (P<0.0001) and for UDS were lower (P<0.05). ConclusionsThe 3dBD showed good feasibility, reliability and validity to be used in the assessment of LUTS in women. Neurourol. Urodynam. 34:128-132, 2015. (c) 2013 Wiley Periodicals, Inc.
Datos de la publicación
- ISSN/ISSNe:
- 0733-2467, 1520-6777
- Tipo:
- Article
- Páginas:
- 128-132
- DOI:
- 10.1002/nau.22530
- Factor de Impacto:
- 0,992 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
NEUROUROLOGY AND URODYNAMICS WILEY
Citas Recibidas en Web of Science: 54
Documentos
- No hay documentos
Filiaciones
Keywords
- bladder diary; lower urinary tract symptoms-LUTS; patient reported outcome measures-PROM; women
Proyectos asociados
ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS, CONTROLADO CON PLACEBO Y CON COMPARADOR ACTIVO Y MULTICÉNTRICO PARA LA EVALUACIÓN DE LA EFICACIA, SEGURIDAD Y TOLERABILIDAD DE COMBINACIONES DE SUCCINATO DE SOLIFENACINA Y MIRABEGRON EN COMPARACIÓN C ON MONOTERAPIAS DE SUCCINATO DE SOLIFENACINA Y DE MIRABEGRON EN EL TRATAMIENTO DE VEJIGA HIPERACTIVA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
178-CL-101 . 2014
ESTUDIO DE EVALUACION DE LA FACTIVILIDAD, VALIDEZ Y FIABILIDAD DEL DIARIO MICCIONAL DE 3 DIAS, EN MUJERES ATENDIDAS EN UNIDADES DE UROLOGIA FUNCIONAL Y URODINAMICA. ESTUDIO DM3D.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
VH01-10 . 2011
ESTUDIO SOBRE PRÁCTICA CLÍNICA HABITUAL EN PACIENTES CON SÍNDROME DE DOLOR VESICAL (SDV) EN UNIDADES DE UROLOGÍA FUNCIONAL Y URODINÁMICA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
AST-URO-13-02 . 2014
ESTUDIO DE EVALUACION DE LA VEJIGA HIPERACTIVA Y HIPERACTIVIDAD DEL DETRUSOR EN VARONES CON SINTOMAS DEL TRACTO URINARIO INFERIOR (STUI) DE LLENADO QUE ACUDEN A UNIDADES DE UROLOGIA FUNCIONAL Y URODINAMICA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
VH02-11 . 2011
ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS, CONTROL ACTIVO Y MULTICÉNTRICO PARA LA EVALUACIÓN DE LA SEGURIDAD Y LA EFICACIA A LARGO PLAZO DE LA COMBINACIÓN DE SUCCINATO DE SOLIFENACINA CON MIRABEGRON EN COMPARACIÓN CON MONOTERAPIAS DE SUCCINAT O DE SOLIFENACINA Y DE MIRABEGRON EN SUJETOS CON VEJIGA HIPERACTIVA.
Investigador Principal: SALVADOR ARLANDIS GUZMÁN
178-CL-102 . 2015
Cita
Jimenez MA,Lopez L,Esteban M,Prieto L,Llorens FJ,Salinas J,Castro D,Muller C,Adot JM,Rodriguez F,Gutierrez C,Arlandis S,Bonillo MA,Madurga B,Leva M,Franco de Castro A,Peri L,Conejero J,Jimenez J,Rebollo P,Mora A. The 3-Day Bladder Diary Is a Feasible, Reliable and Valid Tool to Evaluate the Lower Urinary Tract Symptoms in Women. Neurourol Urodyn. 2015. 34. (2):p. 128-132. IF:3,128. (1).